Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.

Article  PubMed  Google Scholar 

Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, et al. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2023;20:203–22.

Article  PubMed  Google Scholar 

Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138:103–41.

Article  PubMed  CAS  Google Scholar 

Yu J, Xia X, Dong Y, Gong Z, Li G, Chen GG, et al. CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling. Theranostics. 2021;11:2123–36.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu L, Yang X, Feng J, Mao J, Zhang Q, He M, et al. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-Catenin signaling. J Transl Med. 2022;20:194.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang F, Chen L, Yang YC, Wang XM, Wang RY, Li L, et al. CYP3A5 functions as a tumor suppressor in hepatocellular carcinoma by regulating mTORC2/Akt signaling. Cancer Res. 2015;75:1470–81.

Article  PubMed  CAS  Google Scholar 

Abu-Bakar A, Hakkola J, Juvonen R, Rahnasto RM, Raunio H, Lang MA. Function and regulation of the CYP2A5/CYP2A6 genes in response to toxic insults in the liver. Curr Drug Metab. 2013;14:137–50.

Article  PubMed  CAS  Google Scholar 

Ren X, Ji Y, Jiang X, Qi X. Downregulation of CYP2A6 and CYP2C8 in tumor tissues is linked to worse overall survival and recurrence-free survival from hepatocellular carcinoma. Biomed Res Int. 2018;2018:5859415.

Article  PubMed  PubMed Central  Google Scholar 

Fang Y, Chen G, Chen F, Hu E, Dong X, Li Z, et al. Accurate transcriptome assembly by nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma. Cancer Sci. 2021;112:3555–68.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang T, Zhu AS, Yang CQ, Xu CY, Yang DQ, Lou ZH, et al. Cytochrome P450 2A6 is associated with macrophage polarization and is a potential biomarker for hepatocellular carcinoma. FEBS Open Bio. 2021;11:670–83.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Waxman DJ, Chang TK. Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation. Methods Mol Biol. 1998;107:111–6.

PubMed  CAS  Google Scholar 

Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357:eaan2507.

Article  PubMed  Google Scholar 

Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556–60.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342–8.

Article  PubMed  CAS  Google Scholar 

Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.

Article  PubMed  PubMed Central  Google Scholar 

Abu-Bakar A, Arthur DM, Wikman AS, Rahnasto M, Juvonen RO, Vepsäläinen J, et al. Metabolism of bilirubin by human cytochrome p450 2A6. Toxicol Appl Pharmacol. 2012;261:50–8.

Article  PubMed  CAS  Google Scholar 

Meunier B, de Visser SP, Shaik S. Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. Chem Rev. 2004;104:3947–80.

Article  PubMed  CAS  Google Scholar 

Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956–63.

Article  PubMed  CAS  Google Scholar 

Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69–84.

Article  PubMed  CAS  Google Scholar 

Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The String database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605–12.

Article  PubMed  CAS  Google Scholar 

Consortium U. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 2023;51:D523–31.

Article  Google Scholar 

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1–3.

Article  PubMed  Google Scholar 

Yano JK, Hsu MH, Griffin KJ, Stout CD, Johnson EF. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat Struct Mol Biol. 2005;12:822–3.

Article  PubMed  CAS  Google Scholar 

Hennequin LF, Allen J, Breed J, Curwen J, Fennell M, Green TP. et al. N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. J Med Chem. 2006;49:6465–88.

Article  PubMed  CAS  Google Scholar 

Cowan-Jacob SW, Fendrich G, Manley PW, Jahnke W, Fabbro D, Liebetanz J, et al. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. Structure. 2005;13:861–71.

Article  PubMed  CAS  Google Scholar 

Park T, Baek M, Lee H, Seok C. GalaxyTongDock: symmetric and asymmetric ab initio protein-protein docking web server with improved energy parameters. J Comput Chem. 2019;40:2413–7.

Article  PubMed  CAS  Google Scholar 

Humpton TJ, Hall H, Kiourtis C, Nixon C, Clark W, Hedley A, et al. P53-mediated redox control promotes liver regeneration and maintains liver function in response to CCl4. Cell Death Differ. 2022;29:514–26.

Article  PubMed  CAS  Google Scholar 

Yan T, Lu L, Xie C, Chen J, Peng X, Zhu L, et al. Severely impaired and dysregulated cytochrome p450 expression and activities in hepatocellular carcinoma: implications for personalized treatment in patients. Mol Cancer Ther. 2015;14:2874–86.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim LC, Song L, Haura EB. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol. 2009;6:587–95.

Article  PubMed  Google Scholar 

Luo J, Zou H, Guo Y, Tong T, Ye L, Zhu C, et al. SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. Breast Cancer Res. 2022;24:99.

Article  PubMed  PubMed Central  CAS